Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Revision: v3.6.6 is now shown on the page, replacing Revision: v3.6.5. This indicates a small update to the page's template or content rendering without changing the study information.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedA new footer line 'Revision: v3.6.5' has been added. The text items 'clinical study report synopsis', 'AbbVie', 'Helpful Links Provided by', and the previous 'Revision: v3.6.4' have been removed.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision: v3.6.4 replaces the previous Revision: v3.6.3 on the page. This appears to be a backend/UI update and does not modify study data or visible page content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a small site update. The study details and other content remain unchanged.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, indicating a minor update to the page template. This update does not affect the study details or the information presented to users.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page adds new help/navigation items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision tag to v3.6.0, while the previous label 'Intervention / Treatment' was removed and replaced with 'Intervention/Treatment'.SummaryDifference0.5%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.